Biotech StocksInsightsMost Popular What Analysts Are Saying About Biotech Stocks Achillion Pharmaceuticals, Inc. And ACADIA Pharmaceuticals Inc. Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. Jason Cohen, August 9, 2017
Biotech StocksStock News Achillion Pharmaceuticals, Inc. (ACHN) Shares Skyrocket Following 2Q:17 Results and Clinical Update Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reported financial results for the three and six months ended June 30, 2017. Corey Williams, August 8, 2017
Biotech StocksInsightsMost Popular Here’s Why Maxim Slashed Price Target on Achillion Pharmaceuticals, Inc. (ACHN) Today Maxim analyst Jason Kolbert slashes his price target on shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) to $5. Jason Cohen, April 24, 2017
Biotech StocksStock News Stock Update (NASDAQ:ACHN): Achillion Pharmaceuticals, Inc. Announces $15 Million Clinical Milestone for JNJ-4178 in Phase 2B Development for Chronic HCV Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) announced that it has received a $15 million milestone payment from Janssen Research & Development, LLC. Corey Williams, December 28, 2016
Biotech StocksStock News Company Update (NASDAQ:ACHN): Achillion Pharmaceuticals, Inc. Announces Initiation of Patient Dosing by Janssen in Phase 2b Study of JNJ-4178 in Chronic HCV Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced the start of patient dosing in a global Phase 2b open-label OMEGA-1 study of JNJ-4178, a 3DAA combination … Corey Williams, November 30, 2016
Biotech StocksInsights Achillion Pharmaceuticals (ACHN) Shares Might’ve Just Hit A Bottom; Chardan Upgrades In a research report released Friday, Chardan analyst Madhu Kumar upgraded shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) to a Neutral rating, without providing a price … Jason Cohen, November 4, 2016
Biotech StocksInsights Analysts Speculate on Two Falling Biotech Stocks: Achillion Pharmaceuticals, Inc. (ACHN) and bluebird bio Inc (BLUE) News from Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) and bluebird bio Inc (NASDAQ:BLUE) have sent biotech investors running for the hills and have left shares … Julie Lamb, November 3, 2016
Biotech StocksStock News Achillion Pharmaceuticals, Inc. (ACHN) Provides 3Q:16 Update; Shares Fall 19% Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reported financial results for the three months ended September 30, 2016. Corey Williams, November 3, 2016
Biotech StocksStock News Company Update (NASDAQ:ACHN): Achillion Pharmaceuticals, Inc. Announces Updated Interim Results From Janssen’s Phase 2 Trial in Genotype 1 Treatment-Naïve HCV Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that updated interim results were presented today in an ePoster describing a phase 2 study being conducted by Alios … Corey Williams, September 23, 2016
Biotech StocksStock News Company Update (NASDAQ:ACHN): Achillion Pharmaceuticals, Inc. Presents Novel Research on Factor D Inhibition at the XXVIth International Complement Workshop Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced the presentation of two posters which detailed novel preclinical research into complement biology and the inhibition of factor D … Corey Williams, September 6, 2016
